{"data":{"id":"us/21-cfr-207.54","jurisdiction":"us","citation":"21 CFR 207.54","heading":"What listing information must a registrant submit for a drug that it salvages?","body":"A registrant who also relabels or repacks a drug that it salvages must list the drug it relabels or repacks in accordance with § 207.53 rather than in accordance with this section. A registrant who performs only salvaging with respect to a drug must provide the following listing information for that drug.\n(a) The NDC assigned to the drug immediately before the drug is received by the registrant for salvaging;\n(b) The lot number and expiration date of the salvaged drug product; and\n(c) The name and Unique Facility Identifier for each establishment where the registrant salvages the drug.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER C—DRUGS: GENERAL","PART 207—REQUIREMENTS FOR FOREIGN AND DOMESTIC ESTABLISHMENT REGISTRATION AND LISTING FOR HUMAN DRUGS, INCLUDING DRUGS THAT ARE REGULATED UNDER A BIOLOGICS LICENSE APPLICATION, AND ANIMAL DRUGS, AND THE NATIONAL DRUG CODE","Subpart D—Listing"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"2d8be3a7d29536533ec3387bd949a0a45dd623baae6f91203ed6aec2ac1436ff","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-207.53","next":"us/21-cfr-207.55"},"notice":"GroundRules: Original legal text. Not legal advice."}